• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
XU Chen,GAO Qiang,CHENG Yongxian.Chemical constituents from Ganoderma lucidum and their anti-triple negative breast cancer activities[J].Journal Of Pharmaceutical Research,2025,44(8):737-742,755[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 1975times   Download 745次 QR Code for this article
Scan with your phone!
赤芝的化学成分及其抗三阴性乳腺癌活性研究
许宸1,2,高强2,程永现1,2
Font:Larger+|Default|Smaller-
(1.广东药科大学药学院,广东 广州 510006;2.深圳大学医学部药学院,中医药守正创新研究院,广东省中药有效成分与肠道微生物组学重点实验室,广东 深圳 518060)
摘要:
目的 研究赤芝Ganoderma lucidum的化学成分并对其抗三阴性乳腺癌活性进行初步评价。方法 通过各种色谱技术从干燥赤芝子实体中分离出单体化合物,结合一维二维核磁图谱以及高分辨质谱等数据进行结构鉴定。采用CCK-8法筛选对MDA-MB-231细胞具有增殖抑制作用的化合物,并测定半数抑制浓度(IC50)。结果 从赤芝80%乙醇提取物的乙酸乙酯部位中分离鉴定5个新化合物,bslingzhines A~E (1~5)。结论 化合物1~5为新的羊毛脂甾烷类三萜,它们在体外抗三阴性乳腺癌活性均较弱
关键词:  赤芝  化学成分  羊毛脂甾烷三萜  三阴性乳腺癌
DOI:10.13506/j.cnki.jpr.2025.08.002
基金项目:国家自然科学基金项目(No.82030115)
Publication Date:August 25, 2025
Chemical constituents from Ganoderma lucidum and their anti-triple negative breast cancer activities
XU Chen1,2,GAO Qiang2,CHENG Yongxian1,2
(1. School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; 2. Guangdong Key Laboratory of Chinese Medicine Ingredients and Gut Microbiomics; Institute for Inheritance-Based Innovation of Chinese Medicine; School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen 518060, China)
Abstract:
Objective To investigate the chemical constituents of Ganoderma lucidum and evaluate their anti-triple negative breast cancer activities. Methods The structures were isolated using diverse column chromatography techniques from the fruiting bodies of Ganoderma lucidum and identified by 1D, 2D NMR and HRESIMS data. Compounds that can inhibit MDA-MB-231 cells proliferation were initially screened through CCK-8 and IC50 assay. Results Five new compounds were isolated from the ethyl acetate fraction of the 80% ethanol extract of G lucidum. The structures were identified as bslingzhines A–E (1–5). Conclusion Compounds 1–5 are new lanostane triterpenoids with weak or without in vitro anti-tumor ability.
Key words:  Ganoderma lucidum  Chemical constituents  Lanostane triterpenoids  Triple negative breast cancer
Today's Visits:487    Total Visits:2383201
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.